← Back to headlines
Dr. Reddy's Biosimilar for Bristol's Orencia Undergoes FDA Review
Dr. Reddy's biosimilar for Bristol's Orencia is currently undergoing FDA review, marking a significant step in the development of new treatment options.
20 Feb, 16:40 — 20 Feb, 16:40
Read at source (1 outlet)
Related Stories
Africa CDC Advocates for Health Financing Reforms and Local Vaccine Production
8m ago
Nigeria Battles Lassa Fever Outbreak with New Cases and Deaths Reported
18m ago
UNICEF Registers 14 Million Births in Nigeria, Digitalizing System
18m ago
Man's Nightly Bathroom Habit Leads to Prostate Cancer Diagnosis
48m ago